Sign Up Today and Learn More About Obsidian Therapeutics Stock
Invest in or calculate the value of your shares in Obsidian Therapeutics or other pre-IPO companies through EquityZen's platform.
![Obsidian Therapeutics](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/obsidiantherapeutics_logo-2aad10741281aa95.png)
Obsidian Therapeutics Stock
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
About Obsidian Therapeutics Stock
Founded
2015
Headquarters
Cambridge, MA, US
Industries
Obsidian Therapeutics Press Mentions
Stay in the know about the latest news on Obsidian Therapeutics
The biggest private biotech investments in April 2024
labiotech • Jun 26, 2024
Biopharma Company Obsidian Therapeutics Raises $160.5M
builtinboston • May 23, 2024
Obsidian Therapeutics Appoints Jeffrey Trigilio as Chief Financial Officer
citybiz • May 05, 2024
Obsidian Therapeutics: Cell And Gene Therapies Company Raises $160.5 Million
pulse2 • May 05, 2024
Obsidian Therapeutics Secures $160.5M Series C Financing for Innovative Cell Therapy
synbiobeta • May 05, 2024
Obsidian Therapeutics Management
Leadership team at Obsidian Therapeutics
Senior Vice President & Head of Research
Steve Shamah
CSO
Jan Ter Meulen
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Obsidian Therapeutics current valuation
- Obsidian Therapeutics stock price
- Available deals in Obsidian Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Obsidian Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Obsidian Therapeutics through EquityZen funds. These investments are made available by existing Obsidian Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Obsidian Therapeutics stock?
Shareholders can sell their Obsidian Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."